- Home
- ZURA vs JSPR Comparison
ZURA vs JSPR Comparison
Compare ZURA & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- JSPR
- Stock Information
- Founded
- ZURA 2022
- JSPR 2018
- Country
- ZURA United States
- JSPR United States
- Employees
- ZURA N/A
- JSPR N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZURA Health Care
- JSPR Health Care
- Exchange
- ZURA Nasdaq
- JSPR Nasdaq
- Market Cap
- ZURA 69.9M
- JSPR 85.8M
- IPO Year
- ZURA N/A
- JSPR N/A
- Fundamental
- Price
- ZURA $1.13
- JSPR $6.70
- Analyst Decision
- ZURA Buy
- JSPR Strong Buy
- Analyst Count
- ZURA 7
- JSPR 9
- Target Price
- ZURA $14.33
- JSPR $59.25
- AVG Volume (30 Days)
- ZURA 709.5K
- JSPR 386.0K
- Earning Date
- ZURA 08-08-2025
- JSPR 08-12-2025
- Dividend Yield
- ZURA N/A
- JSPR N/A
- EPS Growth
- ZURA N/A
- JSPR N/A
- EPS
- ZURA N/A
- JSPR N/A
- Revenue
- ZURA N/A
- JSPR N/A
- Revenue This Year
- ZURA N/A
- JSPR N/A
- Revenue Next Year
- ZURA N/A
- JSPR N/A
- P/E Ratio
- ZURA N/A
- JSPR N/A
- Revenue Growth
- ZURA N/A
- JSPR N/A
- 52 Week Low
- ZURA $0.97
- JSPR $3.13
- 52 Week High
- ZURA $5.07
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- ZURA 48.73
- JSPR 73.64
- Support Level
- ZURA $1.00
- JSPR $5.35
- Resistance Level
- ZURA $1.22
- JSPR $5.72
- Average True Range (ATR)
- ZURA 0.08
- JSPR 0.51
- MACD
- ZURA -0.00
- JSPR 0.12
- Stochastic Oscillator
- ZURA 52.00
- JSPR 89.77
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.